Genetic Technologies Limited
Method for modifying a treatment regimen of a human female subject

Abstract:

The present disclosure relates to methods and systems for assessing the risk of a human female subject for developing breast cancer. In particular, the present disclosure relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.